[HTML][HTML] Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure

EP Tsounis, E Tourkochristou, A Mouzaki… - World journal of …, 2021 - ncbi.nlm.nih.gov
Hepatitis B virus (HBV) infection, although preventable by vaccination, remains a global
health problem and a major cause of chronic liver disease. Although current treatment …

Cyanation: a photochemical approach and applications in organic synthesis

RI Patel, S Sharma, A Sharma - Organic Chemistry Frontiers, 2021 - pubs.rsc.org
Photoredox chemistry has emerged as an efficient tool in catalyzing organic reactions as it
utilizes light as an energy source without any external initiator or reagent. The cyanide group …

AI-driven synthetic route design incorporated with retrosynthesis knowledge

S Ishida, K Terayama, R Kojima… - Journal of chemical …, 2022 - ACS Publications
Computer-aided synthesis planning (CASP) aims to assist chemists in performing
retrosynthetic analysis for which they utilize their experiments, intuition, and knowledge …

Current progress in the development of hepatitis B virus capsid assembly modulators: chemical structure, mode-of-action and efficacy

H Kim, C Ko, JY Lee, M Kim - Molecules, 2021 - mdpi.com
Hepatitis B virus (HBV) is a major causative agent of human hepatitis. Its viral genome
comprises partially double-stranded DNA, which is complexed with viral polymerase within …

Progression of antiviral agents targeting viral polymerases

S Peng, H Wang, Z Wang, Q Wang - Molecules, 2022 - mdpi.com
Viral DNA and RNA polymerases are two kinds of very important enzymes that synthesize
the genetic materials of the virus itself, and they have become extremely favorable targets for …

Concise synthesis of spirocyclic dihydrophthalazines through spiroannulation reactions of aryl azomethine imines with cyclic diazo compounds

X Cai, X Song, Q Zhu, X Zhang… - The Journal of Organic …, 2022 - ACS Publications
Spiroannulation reactions are fundamental and invaluable for the synthesis of spirocyclic
compounds. Presented herein are novel cascade reactions of aryl azomethine imines with …

Privileged scaffolds for potent and specific inhibitors of mono-ADP-ribosylating PARPs

MG Nizi, C Sarnari, O Tabarrini - Molecules, 2023 - mdpi.com
The identification of new targets to address unmet medical needs, better in a personalized
way, is an urgent necessity. The introduction of PARP1 inhibitors into therapy, almost ten …

Discovery of novel cccDNA reducers toward the cure of hepatitis B virus infection

D Chen, X Tan, W Chen, Y Liu, C Li, J Wu… - Journal of Medicinal …, 2022 - ACS Publications
Chronic hepatitis B virus (HBV) infection is a worldwide disease that causes thousands of
deaths per year. Currently, there is no therapeutic that can completely cure already infected …

[HTML][HTML] JNJ-64794964 (AL-034/TQ-A3334), a TLR7 agonist, induces sustained anti-HBV activity in AAV/HBV mice via non-cytolytic mechanisms

F Herschke, C Li, R Zhu, Q Han, Q Wu, Q Lu… - Antiviral Research, 2021 - Elsevier
Abstract JNJ-64794964 (JNJ-4964/AL-034/TQ-A3334), an oral toll-like receptor 7 agonist, is
being investigated for the treatment of chronic hepatitis B (CHB), a condition with a high …

Medicinal chemistry strategies in the discovery and optimization of HBV core protein allosteric modulators (2018–2022 update)

X Shao, S Xu, X Wan, Y Zhou, S Wang, S Wu, Y Li… - Chinese Chemical …, 2023 - Elsevier
Despite the improving coverage of preventative vaccines, hepatitis B remains a severe
global public health problem, with more than 250 million patients living with hepatitis B virus …